Mychesco
Published October 11, 2026
FDA Seeks Input on Ibogaine Trials Amid Safety Concerns - MyChesCo
Read the full story at Mychesco
— The U.S. Food and Drug Administration is seeking public input on safety requirements and clinical trial designs for ibogaine, a psychedelic compound.
Surfaced by 2 Google Alerts
- Psychedelics
- Ibogaine